B-cell populations discriminate between pediatric- and adult-onset multiple sclerosis
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective: To comparatively assess the B-cell composition in blood and CSF of patients with pediatric-onset multiple sclerosis (pedMS) and adult-onset multiple sclerosis (adMS).
Methods: In this cross-sectional study, we obtained blood and CSF samples from 25 patients with pedMS (8–18 years) and 40 patients with adMS (23–65 years) and blood specimens from 66 controls (1–55 years). By using multicolor flow cytometry, we identified naive, transitional, isotype class-switched memory, nonswitched memory, and double-negative memory B-cell subsets as well as plasmablasts (PB) and terminally differentiated plasma cells (PC). Flow cytometric data were compared to concentrations of B-cell-specific cytokines in serum and CSF as determined by ELISA.
Results: Frequencies of circulating naive B-cells decreased with higher age in controls but not in patients with multiple sclerosis (MS). B-cell patterns in CSF differed between pedMS and adMS with an acute relapse: in pedMS-derived CSF samples, high frequencies of nonswitched memory B cells and PB were present, whereas class-switched memory B cells and PC dominated in the CSF of patients with adMS. In pedMS, PB were also elevated in the periphery. Accumulation of PB in the CSF correlated with high intrathecal CXCL-13 levels and augmented intrathecal synthesis of immunoglobulin G and immunoglobulin M.
Conclusions: We demonstrate distinct changes in intrathecal B-cell homeostasis in patients with pedMS during active disease, which differ from those in adults by an expansion of plasmablasts in blood and CSF and similarly occur in prototypic autoantibody-driven autoimmune disorders. This emphasizes the particular importance of activated B-lymphocyte subsets for disease progression in the earliest clinical stages of MS.
GLOSSARY
- adMS=
- adult-onset multiple sclerosis;
- ASC=
- antibody-secreting cells;
- CIS=
- clinically isolated syndrome;
- CSM=
- class-switched memory;
- FITC=
- fluorescein isothiocyanate;
- IFN=
- interferon;
- IgG=
- immunoglobulin G;
- IgM=
- immunoglobulin M;
- IL=
- interleukin;
- MS=
- multiple sclerosis;
- NMO=
- neuromyelitis optica;
- ON=
- optic neuritis;
- PBMC=
- peripheral blood mononuclear cells;
- pedMS=
- pediatric-onset multiple sclerosis;
- SLE=
- systemic lupus erythematosus;
- USM=
- unswitched memory;
- VLA-4=
- very late antigen–4
Footnotes
↵* These authors share senior authorship.
Funding information and disclosures are provided at the end of the article. Go to Neurology.org/nn for full disclosure forms. The Article Processing Charge was paid by the Research Grant.
Supplemental data at Neurology.org/nn
- Received August 25, 2016.
- Accepted in final form October 31, 2016.
- Copyright © 2016 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
B-Cell Compartmental Features and Molecular Basis for Therapy in Autoimmune DiseaseChao Zhang, Tian-Xiang Zhang, Ye Liu et al.Neurology: Neuroimmunology & Neuroinflammation, August 31, 2021 -
Article
Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsetsSteven K. Lundy, Qi Wu, Qin Wang et al.Neurology - Neuroimmunology Neuroinflammation, March 03, 2016 -
Article
Immunologic profiles of multiple sclerosis treatments reveal shared early B cell alterationsJames Dooley, Ine Pauwels, Dean Franckaert et al.Neurology - Neuroimmunology Neuroinflammation, May 10, 2016 -
Article
Effects of Natalizumab Therapy on Intrathecal Immunoglobulin G Production Indicate Targeting of PlasmablastsMiriam Schlüter, Eva Oswald, Stephan Winklmeier et al.Neurology: Neuroimmunology & Neuroinflammation, July 01, 2021